Effects of low dose aspirin on immunity during pregnancy
Official title: Immunomodulation During Pregnancy Through Low-Dose Aspirin: a Hypothetical Mechanism for the Prevention of Preeclampsia?
Run by Unidade Local de Saúde de Coimbra, EPE · NCT06882850 · Data updated 2026-11-12
This study is testing how low dose aspirin affects the immune system in pregnant women who are at high risk for preeclampsia to see if it helps improve their health and the health of their babies.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 30 (estimated) |
| Sponsor | Unidade Local de Saúde de Coimbra, EPE Academic / other |
| Locations | 1 site (Coimbra, Coimbra District) |
| Status | Recruiting |
| Started | February 1, 2024 |
| Main results expected | March 30, 2025 |
| Study ends | March 31, 2025 |
| Registry record updated | March 19, 2025 |
| Trial ID | NCT06882850 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pregnant women with singleton pregnancies classified as high risk for preeclampsia who have not previously taken low dose aspirin.
✕Probably not a fit
Patients with multiple pregnancies, autoimmune diseases, or a history of spontaneous miscarriages may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate how low dose aspirin (LDA) affects the immune system in pregnant women at high risk for preeclampsia (PE). It will assess the modulation of various immune cells and quantify pro-inflammatory and anti-inflammatory cytokines before and after LDA administration. The study will include singleton pregnancies monitored at the Centro Hospitalar e Universitário de Coimbra, with participants classified as high-risk for PE based on specific clinical criteria. The study will last between 40 weeks and 24 months, focusing on maternal and fetal outcomes in comparison to low-risk pregnancies.
Why it matters
Potential benefit: If successful, this study could provide insights into how low dose aspirin may improve immune responses and pregnancy outcomes for women at risk of preeclampsia.
How similar studies have gone: While this approach is observational and builds on existing knowledge of aspirin's effects, similar studies have shown promising results in understanding the immunological impacts of aspirin during pregnancy.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: - Singleton pregnancy * Patients attending prenatal consultations at the Obstetrics Service A of CHUC, with the first consultation occurring before 14 weeks of gestation * Gestational age determined by first-trimester ultrasound * Study group: Women classified as high risk for PE according to clinical/historical criteria and the Fetal Medicine Foundation algorithm. LDA-naïve. Exclusion Criteria: Multiple pregnancy * Autoimmune diseases * Prior use of LDA or other immunomodulatory medication before potential recruitment * History of spontaneous miscarriages and/or medical termination of pregnancy * Fetal malformation
Where it's running
-
Unidade Local de Saúde de Coimbra, E.P.E.
Coimbra, Coimbra District, Portugal Recruiting
Study contacts
- Principal investigator: Ana L Areia, PhD MD — University of Coimbra
- Study coordinator: Ana L Areia, PhD, MD
- Email: analuisareia@gmail.com
- Phone: +351917212222
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Two-Door Doulas: Enhanced vs Standard Medicaid Doula Care in Pregnancy
This trial tests whether an enhanced, earlier, and more frequent doula support program helps pregnant people on Medicaid feel less depression and anxiety after birth compared with the standard Medicaid doula care in Florida.
-
See if stopping long-term aspirin is as good as continuing it in older adults with stable ischemic heart disease
In adults 65 and older with stable ischemic heart disease, this trial tests whether stopping daily low-dose aspirin is not worse than continuing it.
-
ASPIRE: Predicting Pregnancy Complications Using Blood and Eye Imaging
This study tests whether blood and eye imaging biomarkers can predict conditions like preeclampsia, fetal growth restriction, and gestational diabetes in first-time pregnant people carrying one baby.
-
Womb Watch: using a smartphone app to detect fetal movements
This study tests a smartphone app to help pregnant people track fetal movements and see if it can better detect movement changes that might signal risk.
-
Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes
This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.
-
Leg vs Arm Ergometer Exercise for Gestational Diabetes
This study tests whether leg-ergometer exercise helps control blood sugar and reduce stress more than arm-ergometer exercise in pregnant people with gestational diabetes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.